| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $18.16 | $136,200.00 | -1.2% | |
| Sep 5, 2019 | Watts Ryan J.77 | President And CEO | Sell | 8,581 | $18.05 | $154,894.23 | -0.2% | |
| Aug 7, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $18.81 | $141,075.00 | -1.2% | |
| Jul 8, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $20.28 | $152,135.00 | -0.6% | |
| Jul 8, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 17,500 | $20.29 | $355,011.26 | -9.4% | |
| Jul 1, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $20.76 | $380,593.08 | -0.7% | |
| Jun 10, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 17,500 | $18.78 | $328,653.42 | -16.1% | |
| Jun 10, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $18.77 | $140,775.00 | -1.2% | |
| Jun 3, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $19.07 | $349,610.31 | -0.7% | |
| May 13, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $22.05 | $165,350.00 | -0.4% |